Pink Sheet Podcast: US FDA Commissioner Nominee Stephen Hahn Appears Before The Senate, Controversial Regulations In The New Unified Agenda
Executive SummaryPink Sheet reporters explain Stephen Hahn's responses to Senators' questions and discuss some of the new regulations that FDA plans to release in the coming months.
You may also be interested in...
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.
Keeping Track: Vascepa Adds CV Risk Reduction Claim, Vyondys 53 Get A Stunning Approval, And Submissions Pour Into FDA
The latest drug development news and highlights from our US FDA Performance Tracker.